Dear all, we decided to leave twitter / X
You can find us on Bluesky: weersmalab.bsky.social
WeersmaLab retweeted
Our Consensus statement on #microbiome testing in clinical practice is out in @LancetGastroHep! authors.elsevier.com/a/1kDP5… Here we recommend how to standardise the framework for test release (indications, pre-testing protocols, sequencing & analysis, result reporting). A thread🧵⬇️
WeersmaLab retweeted
#GUTImage from the #RecentAdvancesInClinicalPractice paper by @arnauvich et al on
"Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases" via
bit.ly/4dyIID3
@WeersmaLab #IBD
Congratulations to Laura Bolte @umcg. Cum Laude distinction for her PhD studying the relation between #diet #microbiome and #immunity in #ibd and response to immune checkpoint inhibition. Work in her PhD thesis has been published in @NatureMedicine @Gut_BMJ and @JAMAOnc
WeersmaLab retweeted
📢 New Study Alert! 📢Happy to share the latest results from the Lifelines NEXT Mother-Infant cohort! (1/8). Here we profile the gut microbiome in 4,577 longitudinal samples from 714 mother-infant pairs, from 12 weeks of pregnancy to 1 year post-birth doi.org/10.21203/rs.3.rs-533…
WeersmaLab retweeted
I am incredibly proud that 2 out of the 5 top abstracts #UEGWeek are from our department @umcg (out of >3500 abstracts). Huge congratulations to @BourgonjeArno and Anne van der Waai for their groundbreaking work and this important recognition!
@my_UEG @LifelinesNL @researchumcg
WeersmaLab retweeted
#GUTImage from the #RecentAdvancesInClinicalPractice paper by @arnauvich et al on
"Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases" via
bit.ly/4dyIID3
@WeersmaLab #IBD
WeersmaLab retweeted
Amazing meeting at the Paris Immuno-Oncology Conference 2024! So much food for thought from top leaders in microbiome and immunology: @EranElinav, @derosa__lisa, @nsegata, @WeersmaLab, and more. Honored to present our latest work published in @NatImmunol with @julienCMarie1.
I am incredibly proud that 2 out of the 5 top abstracts #UEGWeek are from our department @umcg (out of >3500 abstracts). Huge congratulations to @BourgonjeArno and Anne van der Waai for their groundbreaking work and this important recognition!
@my_UEG @LifelinesNL @researchumcg
WeersmaLab retweeted
#GUTImage from the #RecentAdvancesInClinicalPractice paper by @arnauvich et al on
"Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases" via
bit.ly/4dyIID3
@WeersmaLab #IBD
WeersmaLab retweeted
Join us on October 13 for the presentation of our Top Abstract Prize Awardee, Arno R. Bourgonje:
CROHN'S DISEASE AND ULCERATIVE COLITIS EXHIBIT PRE-DIAGNOSTIC ANTIBODY SIGNATURES WITH SHARED AND DIVERGENT CHANGES TOWARDS DISEASE ONSET 🔬
👉 bit.ly/3yIvcOg
#UEGWeek
WeersmaLab retweeted
The gut microbiome acetyltransferase genes were involved in the metabolism of 5-ASA in IBD.
However, new findings from @WeersmaLab et al. didn't replicate the original findings:
gut.bmj.com/content/early/20…
WeersmaLab retweeted
#GUTImage from the paper by @CasSwarte et al on
"Multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid organ transplant recipients" via
bit.ly/3LcQlTL
@jingyuan_fu @HarmsenHermie @WeersmaLab
In contrast to previous reports we found limited predictive value of the gut #microbiome (and #metabolome) for response to biological therapy in #IBD Still small sample sizes but relatively similar to other studies. @GroMicrobiome @umcgmdl @researchumcg
www-tandfonline-com.proxy-ub…
here's the working link to the paper (open access) tandfonline.com/doi/full/10.…
Exploring the previously reported gut #microbiome acetyltransferase genes involved in metabolism of 5-ASA in #ibd we could not replicate the original findings from @NatureMedicine in our Dutch 1000IBD cohort. More work needed. @GroMicrobiome
gut.bmj.com/content/early/20…
WeersmaLab retweeted
#GUTImage from the paper by Gabriels et al entitled
"Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease" via
bit.ly/3YIzWP0
@wouternagengast @researchumcg #IBD #Vedolizumab
WeersmaLab retweeted
(1/6) 📢 New Study Alert! In our randomized controlled trial we compare the gut microbiomes of infants whose mothers received prophylactic antibiotics pre-incision versus post umbilical cord clamping.🤰
doi.org/10.1016/j.chom.2024.…
WeersmaLab retweeted
#GUTPressRelease #GUTInTheNews paper by @CasSwarte et al on
"Multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid organ transplant recipients" via bit.ly/3LcQlTL
@jingyuan_fu @HarmsenHermie @WeersmaLab
WeersmaLab retweeted
Time to slice some fresh ideas…gut microbiome ,genes, IBD …great to reunite with our team & look forward for more learnings & collaborations
@DrThelma @GarimaJuyal @dr_singh_gastro @WeersmaLab @RGacesa @Dr Ajit Sood























